Even if WTO waives IP on vaccines, India will face challenge translating this into mass production | Scroll. in | June 1, 2021
Russian court rejects U.S firm’s lawsuit over COVID-19 drug remdesivir | Reuters | May 28, 2021
Compulsory licensing for Covid vaccines not very attractive option; tech transfer is the key: Govt | The Times of India | May 27, 2021
Russia ships remdesivir drug to India as part of humanitarian aid | Reuters | May 25, 2021
COVID-19 drug Baricitinib: Eli Lilly signs voluntary licensing agreement with Natco Pharma | Money Control | May 17, 2021
India to seek US support on global patent waivers for more Covid gear | Economic Times | May 17, 2021
Patent waiver: India, US seek to rope in others | The Times of India | May 15, 2021
Covid vaccine patents can be waived without hurting firms like Bharat Biotech. Here’s how | The Print | May 14, 2021
Compulsion for Compulsory Licenses for Covid Vaccines Climbs: But Are They the Cure? | SpicyIP | May 14
Why is India calling for a global vaccine patent waiver, but against discussing one at home? | Scroll.in | May 13, 2021
Covid-19 Pandemic Calls for Early Relaxations on IPRs | The Leaflet | May 13, 2021
Bharat Biotech ready to share Covaxin formula with other manufacturers: Centre | Mint | May 13, 2021
On Covid patents waiver, health cannot be held hostage to profit | The Indian Express | May 13, 2021
Govt should issue compulsory licenses to boost covid drugs production: IDMA | Mint | May 13, 2021
China supports talks on intellectual property waiver for Covid-19 vaccines | Hindustan Times | May 13, 2021
Need quick consensus on vaccine patent waiver, transfer of tech to overcome COVID crisis: Piyush ? | The Economic Times | May 12, 2021
As Indian government offers some answers on Covaxin patent rights, more questions emerge | Scroll.in | May 12, 2021
Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license | Knowledge Ecology International | May 11, 2021
A WTO patent waiver on vaccines and technology could be the game changer in Covid-19 battle | Scroll.in | May 11, 2021
PIL In Kerala High Court Seeks Compulsory Licensing Of Covid Vaccines | LiveLaw | May 11, 2021
A TRIPS waiver is useful but not a magic pill | The Hindu | May 10, 2021
Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India | The Economic Times | May 10, 2021
Pharma companies driving policy led to vaccine apartheid: Mohga Kamal-Yanni | The Caravan | May 9, 2021
What would a WTO intellectual property waiver on Covid-19 vaccines mean for India? | Scroll.in | May 9, 2021
Patent Waiver as the New Pandemic Normal: India’s Key Role in an Emerging Global Consensus | Observer Research Foundation | May 9, 2021
Bombay HC Rejects Injunction Plea in Passing Off Action against Serum Institute of India for the ‘Covishield’ Mark | SpicyIP | May 6, 2021
In Major Turnaround, US Announces Support for IP Waiver of Covid Vaccines | SpicyIP | May 6, 2021
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche | SpicyIP | May 5, 2021
Natco Files Compulsory Licence Application for Covid Drug Baricitinib | SpicyIP | May 5, 2021
SC Issues Interim Order in Suo Motu COVID-19 Case: Raises Questions on Vaccine Procurement Process, Compulsory Licensing and More | SpicyIP | May 4, 2021
Natco to request for compulsory license for Baricitinib for Covid-19 treatment | Hindu Business Line | May 3, 2021
Compulsory License under Patent and Competition Law to Ensure Vaccine Equity | Observer Research Foundation | May 3, 2021
ICMR to get royalty from Covaxin sale | The Hindu | May 3, 2021
Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt | Economic Times | May 2, 2021
Supreme Court Weighs in on the Crisis: Vaccine Price Equity, Compulsory Licensing and Free Speech Online | SpicyIP | May 2, 2021
Tech Mahindra, Reagene to file patent for coronavirus attacking molecule | Business Standard | May 2, 2021
India, South Africa to make fresh push for waiver of vaccine patents at WTO | Hindustan Times | May 1, 2021
Politics, pharma, patent, profit or the people of India? A case for compulsory licensing | Bar & Bench | May 1, 2021
Bombay HC orders Centre to include Remdesivir in list of scheduled drugs | The Hindu | May 1, 2021
Grateful to SC for raising issues of vaccine prices, compulsory licensing to vaccine makers: Chidambaram | The New India Express | April 30, 2021
Brazil Senate votes to suspend patent protection on Covid-19 vaccines | Reuters | April 30, 2021
Plea In SC Seeks Authorisation For Use Of Remdesivir, Favipiravir and Tocilizumab For Govt. Purposes And/Or Grant Compulsory Licenses For Their Patent | LiveLaw | April 29, 2021
How Covid-19 vaccination can be accelerated globally without suspending intellectual property rights | Scroll.in | April 28, 2021
White House considering intellectual property waiver for COVID-19 vaccines | Reuters | April 28, 2021
WTO IP waiver too simplistic: Global vaccine tech-transfer needs other strategies | Express Pharma | April 28, 2021
Russian firm awaits government approval to ship Remdesivir to India | Reuters | April 27, 2021
Coronavirus treatment: 5 Indian firms in licensing pact with Merck for Covid-19 oral drug | Mint | April 27, 2021
Innovative anti-Covid face shield gets patent | The New India Express | April 27, 2021
Now is not the time to hanker for patents. WTO must waive IP rights on Covid vaccines | The Print | April 26, 2021
A Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper Nationalism | SpicyIP | April 25, 2021
TRIPS meet: India, S Africa to rework patent proposal | Times of India | April 23, 2021